DRDO approves 2DG for emergency use, here are directions for usage in COVID-19
The Defence Research and Development Organisation`s (DRDO) on Tuesday (June 1) said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.
Jun 01, 2021, 16:24 PM ISTDRDO's anti-COVID drug to be released on May 17, check details
The Drugs Controller General of India (DGCI) has approved the oral drug for emergency use.
May 16, 2021, 22:59 PM IST